University of California, San Diego
University of California, San Diego
San Diego, California, United States29 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Progressive Supranuclear Palsy Clinical Trial Platform | Neurologic Manifestations, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, cranial nerve neuropathy, eye disorder, movement disorder, nervous system disorder, neurodegenerative disease, ophthalmoplegia, palsy, tauopathy | Recruiting | Phase 2 | 2026-10-09 | NCT07173803 | |
| Psilocybin-assisted Therapy for Phantom Limb Pain | Chronic Pain, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Phantom Limb, Phantom Limb Pain, Postoperative Complications, Postoperative Pain, Signs and Symptoms, nervous system disorder, perceptual disorders | Active, not recruiting | Phase 1 | 2026-10-09 | NCT05224336 | |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) | Frontotemporal Lobar Degeneration, Neurologic Manifestations, Nutritional and Metabolic Diseases, Ocular Motility Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, corticobasal degeneration disorder, cranial nerve neuropathy, dementia, eye disorder, frontotemporal dementia, frontotemporal dementia with motor neuron disease, metabolic disease, motor neuron disorder, movement disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, ophthalmoplegia, palsy, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, tauopathy | Recruiting | Not stated | 2026-10-07 | NCT04363684 | |
| Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-10-01 | NCT06252675 | |
| Pramipexole to Enhance Social Connections | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Phase 2 | 2026-09-23 | NCT06269146 | |
| Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) | Hemic and Lymphatic Diseases, Lymphohistiocytosis, Hemophagocytic, histiocytosis, lymphatic system disorder, non-Langerhans cell histiocytosis | Recruiting | Phase 2 | 2026-09-21 | NCT06160791 | |
| A Systems Analysis and Improvement Approach for Optimizing HIV Service Delivery in Syringe Services Programs | Blood-Borne Infections, Chemically-Induced Disorders, Disease Attributes, Genital Diseases, HIV infectious disease, Infections, Narcotic-Related Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-08-24 | NCT06025435 | |
| Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 1 | 2026-07-28 | NCT06710223 | |
| Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG) | Body Weight, Deglutition Disorders, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, digestive system disorder, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-07-14 | NCT06783751 | |
| Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-07-06 | NCT05685745 | |
| Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence | Urgency Urinary Incontinence | Active, not recruiting | Phase 4 | 2026-06-29 | NCT05806164 | |
| Optimizing CBSST With Executive Function Training for Schizophrenia (R33) | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizoaffective disorder, schizophrenia | Not yet recruiting | Not applicable | 2026-06-23 | NCT07658391 | |
| A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures | Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain hypoxia - ischemia, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, perinatal asphyxia, vascular disorder | Recruiting | Phase 2 | 2026-06-15 | NCT05610085 | |
| Vancomycin in TKAs | Total Knee Arthroplasty | Recruiting | Phase 4 | 2026-06-03 | NCT07282782 | |
| A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-04-17 | NCT06307795 | |
| DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, malignant glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2026-03-11 | NCT06504381 | |
| BladdEr Full OR Empty for Pelvic Radiation Therapy | Neoplasms by Site, Pelvic Neoplasms, neoplasm | Recruiting | Phase 3 | 2026-02-17 | NCT06651697 | |
| Comparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries | Ankle Fractures, Leg Injuries, Syndesmotic Injuries, ankle injury, bone fracture, injury | Recruiting | Not applicable | 2026-02-10 | NCT05729542 | |
| Blood Pressure Care for Advancing Real-World Evidence (BPCARE) | cardiovascular disorder, hypertensive disorder, vascular disorder | Recruiting | Not applicable | 2026-02-09 | NCT07398391 | |
| Retrograde Femoral Nail-Advanced Outcomes for Fixation of Distal Femur and Femoral Shaft Fractures | Femoral Fractures, Leg Injuries, bone fracture, injury | Recruiting | Not applicable | 2026-02-09 | NCT05680987 | |
| A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects | Arm Injuries, Femoral Fractures, Leg Injuries, bone fracture, humerus fracture, injury, tibia fracture | Recruiting | Not stated | 2026-02-09 | NCT05668182 | |
| Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial | Pathological Conditions, Signs and Symptoms, Personality Disorders, Prodromal Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, psychiatric disorder, schizotypal personality disorder | Active, not recruiting | Not applicable | 2026-01-26 | NCT04338152 | |
| Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Recruiting | Phase 3 | 2026-01-08 | NCT04411225 | |
| A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients | Artificial Intelligence (AI); Breast Cancer Screening | Recruiting | Phase 4 | 2025-11-26 | NCT06934239 | |
| Mirai-MRI: Validation of AI Models for Breast Cancer Risk | Breast Cancer Risk; Cancer Risk | Recruiting | Not applicable | 2025-11-06 | NCT07121972 |